Aceto Consolidates Acquisition of Six Specialty Manufacturers
January 26, 2022
Aceto has consolidated and integrated six recent manufacturing-related acquisitions — A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem and Syntor Fine Chemicals — to create a hybrid manufacturing/distribution model that strengthens its GMP manufacturing, R&D and supply-chain capabilities across pharmaceuticals, biopharma, vaccines, nutraceuticals, agri-science and specialty chemicals. The acquisitions expand Aceto’s global manufacturing footprint (North America, Europe and Asia), broaden its portfolio of excipients, APIs and process solutions, and improve supply-chain resilience for customers.
- Buyers
- Aceto
- Targets
- A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem, Syntor Fine Chemicals
- Industry
- Pharmaceuticals
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Aceto Acquires A&C (A&C Bio-Buffer)
April 15, 2021
Pharmaceuticals
Aceto has acquired A&C, a global GMP manufacturer of specialty excipients, buffers and process solutions, expanding Aceto's self-manufacturing and custom product capabilities for the vaccine, cell culture and biopharmaceutical markets. The deal adds GMP manufacturing, packaging and ingredient offerings and expands Aceto's North American and European footprint; financial terms were not disclosed.
-
Aceto Acquires A&C Bio Buffer Ltd
October 12, 2021
Pharmaceuticals
Aceto has acquired A&C Bio Buffer Ltd, a GMP manufacturer of custom buffers and chemical blends based in Limerick, Ireland. The acquisition expands Aceto’s GMP product lines and European manufacturing footprint, complementing its earlier purchase of A&C and strengthening capabilities for biopharmaceutical and vaccine manufacturing.
-
Aceto Acquires Cascade Chemistry
June 2, 2021
Pharmaceuticals
Aceto, a global provider of specialty materials for life sciences and advanced technology end markets, acquired Eugene, Oregon-based Cascade Chemistry, a CDMO specializing in active pharmaceutical ingredients (APIs) and advanced intermediates. The acquisition strengthens Aceto's U.S. cGMP custom manufacturing capabilities and expands North American API manufacturing capacity; Cascade Chemistry recently announced a facility expansion that will triple its clinical-stage API capacity.
-
Aceto Acquires IsleChem to Add U.S. Manufacturing and R&D Capabilities
December 21, 2020
Manufacturing
Aceto U.S., LLC has acquired IsleChem, a Grand Island, New York-based chemical manufacturer and contract R&D provider. The acquisition adds U.S. manufacturing, analytical and R&D capabilities to Aceto’s global specialty-chemicals sourcing and distribution platform and supports expansion of IsleChem’s facility and workforce.
-
New Mountain Capital Acquires Aceto Chemicals Business
April 16, 2019
Manufacturing
New Mountain Capital, through an affiliate, agreed to acquire the chemicals business of ACETO Corporation (Aceto), a Port Washington, New York-based supplier and distributor of pharmaceutical ingredients and specialty chemicals. The acquisition is intended to provide Aceto with financial and strategic resources to scale capabilities, pursue organic and inorganic growth, and strengthen its position in life sciences and specialty materials markets.
-
New Mountain-backed Actylis Integrates Aceto and 10 Specialty Ingredients Businesses
September 26, 2022
Manufacturing
New Mountain Capital’s new platform Actylis launched by combining Aceto and ten acquired specialty ingredient manufacturers and sourcing firms into a single global company. The combined business unites GMP and non‑GMP manufacturing, R&D, quality and sourcing capabilities across multiple countries to supply critical raw materials for pharmaceuticals, nutrition, cosmetics, agriculture and specialty chemicals.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.